Previous studies have shown that PIGR is upregulated in several malignancies, such as hepatocellular carcinoma (18) and osteosarcoma (13), and is downregulated in other cancers, including pancreatic cancer (14), breast cancer (15), ovarian cancer (16), and stomach and esophageal cancer (17). Here, PIGR is linked to ovarian cancer.